sc13dza
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13D
Under
the Securities Exchange Act of 1934
(Amendment No. 1)
AMERICAN REALTY INVESTORS, INC.
(Name of Issuer)
Common Stock, $0.01 par value
(Title of Class of Securities)
029174-10-9
R. Neil Crouch
1755 Wittington Place, Suite 340
Dallas, Texas 75234
(972) 243-2762
(972) 243-2764 (Facsimile)
(Name, Address and Telephone Number of Person Authorized to Receive Notices and
Communications)
June 8, 2009
(Date of Event which Requires Filing of this Statement)
If the filing person has previously filed a statement on Schedule 13G to report the acquisition
which is the subject of this Schedule 13D, and is filing this schedule because of Rules 13d-1(b)(3)
or (4), check the following box [ ].
NOTE: Six copies of this statement, including all exhibits, should be filed with the Commission.
See Rule 13d-1(a) for other parties to whom copies are to be sent.
*The remainder of this cover page shall be filled out for a reporting persons’s initial filing on
this form with respect to the subject class of securities, and for any subsequent amendment
containing information which would alter disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be deemed to be “filed” for
the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to
the liabilities of that section of the Act but shall be subject to all other provisions of the Act
(however, see the Notes).
| |
|
|
|
|
|
| 1 |
|
NAMES OF REPORTING PERSON
International Health Products, Inc. |
| |
|
|
| |
|
|
| 2 |
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
|
| |
(a) o |
| |
(b) o |
| |
|
|
| 3 |
|
|
| |
SEC USE
ONLY
o |
| |
|
| |
|
|
| 4 |
|
|
| |
SOURCE OF FUNDS (SEE INSTRUCTIONS)
WC |
| |
|
| |
|
|
| 5 |
|
|
| |
CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e)
o
|
| |
|
| |
|
|
| 6 |
|
|
| |
CITIZENSHIP OR PLACE OF ORGANIZATION
Nevada |
| |
|
| |
|
|
|
| |
7 |
|
|
| |
|
SOLE VOTING POWER
786,817 |
| NUMBER OF |
|
|
| |
|
|
|
| SHARES |
8 |
|
|
| BENEFICIALLY |
|
SHARED VOTING POWER
-0- |
| OWNED BY |
|
|
| |
|
|
|
| EACH |
9 |
|
|
| REPORTING |
|
SOLE DISPOSITIVE POWER
786,817 |
| PERSON |
|
|
| |
|
|
|
| WITH |
10 |
|
|
| |
|
SHARED DISPOSITIVE POWER
-0- |
| |
|
|
| |
|
|
| 11 |
|
|
| |
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 786,817 |
| |
|
| |
|
|
| 12 |
|
|
| |
CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) o |
| |
|
| |
|
|
| 13 |
|
|
| |
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 6.83% |
| |
|
| |
|
|
| 14 |
|
|
| |
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) CO |
| |
|
|
|
|
| Item 1. |
|
Security and Issuer. |
This Amendment No. 1 to Statement on Schedule 13D (this “Amendment”) relates to shares of
Common Stock, par value $0.01 per share (the “Shares”) of American Realty Investors, Inc., a Nevada
corporation (the “Issuer” or “ARL”), which has its principal executive offices located at 1800
Valley View Lane, Suite 300, Dallas, Texas 75234. The Shares are listed and traded on the New York
Stock Exchange, Inc. The CUSIP number of the Shares is 029174-10-9.
This Amendment No. 1 to Schedule 13D is being filed to reflect the acquisition by the
Reporting person of 18,000 Shares on June 8, 2009 in an open market transaction. See item 5 below.
|
|
|
| Item 2. |
|
Identity and Background. |
(a)-(c) and (f) This Amendment is filed on behalf of International Health Products, Inc., a
Nevada corporation (“IHPI” or the “Reporting Person”) which has its principal executive offices
locates at 1755 Wittington Place, Suite 340, Dallas, Texas 75234. All of the issued and
outstanding common stock of IHPI is owned by a trust for the benefit of the spouse and children of
Gene E. Phillips. Each of the director and officer of IHPI is a citizen of the United States of
America.
(d) In the last five years, neither IHPI nor any of its executive officers or
directors has been
convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors).
(e) During the last five years, neither IHPI nor any of its executive officers or
directors
was a party to a civil proceeding of a judicial or administrative body of competent jurisdiction
and as a result of such proceeding was or is subject to a judgment, decree or final order in
joining future violations of, or prohibiting or mandating activities subject to, federal or state
securities laws or finding any violation with respect to such laws.
|
|
|
| Item 3. |
|
Source and Amount of Funds or Other Consideration. |
The consideration paid by IHPI to purchase the 18,000 Shares described in Item 5(c) below
(a total of $201,605) came from its own working capital funds.
|
|
|
| Item 4. |
|
Purpose of Transaction. |
IHPI acquired the Shares described in Item 5 below as an investment. IHPI has no present
plans or proposals which would result in IHPI seeking to acquire the entire equity interest in the
Issuer. Except as set forth in this Statement, IHPI has no present plans or proposals which relate
to or would result in:
| |
(a) |
|
the acquisition by any person of any additional securities of the Issuer or the
disposition of securities of the Issuer except that IHPI may, if the appropriate
opportunity exists, acquire additional securities of the Issuer or dispose of any
portion or all of the securities of the Issuer; or |
| |
(b) |
|
an extraordinary corporate transaction such as a merger, reorganization or
liquidation, involving the Issuer or any of its subsidiaries; or |
| |
| |
(c) |
|
a sale or transfer of a material amount of assets of the Issuer and any of its
subsidiaries; or |
| |
| |
(d) |
|
any change in the present Board of Directors or management of the Issuer,
including any plans or proposals to change the number or term of directors or to fill
any existing vacancies on the Board; or |
| |
| |
(e) |
|
any material change in the present capitalization or dividend policy to Issuer;
or |
| |
| |
(f) |
|
any other material change in the Issuer’s business or corporate structure; or |
| |
| |
(g) |
|
changes in the Issuer’s charter, bylaws or instruments corresponding thereto or
other actions which may impede the acquisition of control of the Issuer by any person;
or |
| |
| |
(h) |
|
causing of a class of securities of the Issuer to be delisted from a national
securities exchange or to cease to be authorized to be quoted in an inter-dealer
quotation system of a registered national securities association; or |
| |
| |
(i) |
|
a class of equity securities of the Issuer becoming eligible for termination of
registration pursuant to Section 12(g)(4) of the Exchange Act; or |
| |
| |
(j) |
|
any actions similar to any of those enumerated above. |
|
|
|
| Item 5. |
|
Interest in Securities of the Issuer. |
(1) According to the latest information available from the Issuer, as of May 15, 2009, the
total number of issued and outstanding Shares was 11,514,038 Shares. As of June 8, 2009, after
giving effect to the transaction described in Item 5(c) below, IHPI as the Reporting Person owns
and holds directly and beneficially 786,817 Shares or approximately 6.83% of a class of outstanding
Shares. Pursuant to Rule 13d-3 under the Exchange Act, each of the directors of IHPI may be deemed
to beneficially own the number of Shares owned by IHPI described above. The only director of IHPI
is R. Neil Crouch II who may be deemed to beneficially own pursuant to Rule 13d-3 the 786,817
Shares or approximately 6.83% of the class outstanding. Pursuant to Rule 13d-4, Mr. Crouch
expressly declares that the filing of this Amendment shall not be construed as an admission that
Mr. Crouch is, for the purposes of Section 13d or 13g of the Exchange Act, the beneficial owner of
any securities covered by this Statement.
(2) Each of the directors of IHPI share voting and dispositive power over the 786,817 Shares
held by IHPI.
(3) During the sixty calendar days ended June 8, 2009, the Reporting Person and its executive
officers and did not engage in any transaction involving the Shares or any other equity interests
derivative thereof, except for IHPI’s acquisition of 18,000 Shares as a single block in an open
market transaction for an aggregate purchase price of $210,605 (approximately $11.70 per Share).
The 18,000 Shares purcahsed constitute only 0.156% of the reported outstanding Shares. IHPI has
owned an additional 768,817 Shares since June 30, 2008.
(4) No person other than IHPI or its Board of Directors is known to have the right to receive
or the power to direct the receipt of dividends from, or proceeds of sale of, the Shares of ARL
Common Stock held by IHPI.
(5) Not applicable.
Item 6. Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the
Issuer.
IHPI does not have any contracts, arrangements, understandings or relationships (legal or
otherwise) with any person with respect to any securities of the Issuer, including, but not limited
to, transfer or voting of the securities, finders’ fees, joint ventures, loan or option
arrangements, puts or calls, guarantees of profits, divisions of profits or loss, or the giving or
withholding of proxies.
|
|
|
| Item 7. |
|
Material to be Filed as Exhibits. |
Not applicable.
SIGNATURES
After reasonable inquiry and to the best of its knowledge and belief, the undersigned certify
that the information set forth on this Statement on Schedule 13D is true, complete and correct.
Dated: June 12, 2009
| |
|
|
|
|
|
|
| |
|
INTERNATIONAL HEALTH PRODUCTS, INC. |
|
|
|
|
|
|
|
|
|
|
|
By:
|
|
/S/ R. NEIL CROUCH
|
|
|
|
|
|
|
R. Neil Crouch, President |
|
|